Acute Kidney Injury and Kidney Replacement Therapy in the Critically Ill Patient

Acute Kidney Injury

Bairy M. Using kinetic eGFR for drug dosing in AKI:

concordance between kinetic eGFR, Cockcroft-Gault

estimated creatinine clearance, and MDRD eGFR for

drug dosing categories in a pilot study cohort. Nephron.

2020;144(6):299-303. https://doi.org/10.1159/000507260

Barreto EF, Gaggani AM, Hernandez BN, et al. The

(AKIP) list: standardized list of medications that are

renally eliminated and nephrotoxic in the acutely ill.

org/10.1177/10600280241273191

Bellomo R, Ronco C, Kellum JA, et al; Acute Dialysis

Quality Initiative Workgroup. Acute renal failure—

definition, outcome measures, animal models, fluid

therapy and information technology needs: the Second

International Consensus Conference of the Acute

2004;8(4):R204-R212. https://doi.org/10.1186/cc2872

Bentley ML, Corwin HL, Dasta J. Drug-induced

acute kidney injury in the critically ill adult: rec-

2010;38(6

suppl):S169-S174.

https://doi.org/10.1097/

ccm.0b013e3181de0c60

Campbell RE, Chen CH, Edelstein CL. Overview

of

antibiotic-induced

nephrotoxicity.

Kidney

Int

Rep.

2023;8(11):2211-2225.

https://doi.org/10.1016/j.

ekir.2023.08.031

Chen S. Retooling the creatinine clearance equation

to estimate kinetic GFR when the plasma creatinine is

changing acutely. J Am Soc Nephrol. 2013;24(6):877-

888. https://doi.org/10.1681/asn.2012070653

Göcze I, Jauch D, Götz M, et al. Biomarker-guided

intervention to prevent acute kidney injury after major

surgery: the prospective randomized BigpAK study. Ann

Surg. 2018;267(6):1013-1020. https://doi.org/10.1097/

sla.0000000000002485

Clin.

2021;37(2):303-320.

https://doi.org/10.1016/j.

ccc.2020.11.002

Karimzadeh I, Barreto EF, Kellum JA, et al. Moving

toward a contemporary classification of drug-induced

org/10.1186/s13054-023-04720-2

Kellum JA, Romagnani P, Ashuntantang G, Ronco

C, Zarbock A, Anders HJ. Acute kidney injury. Nat

Rev Dis Primers. 2021;7(1):52. https://doi.org/10.1038/

s41572-021-00284-z

Kidney Disease: Improving Global Outcomes (KDIGO)

Acute Kidney Injury Work Group. KDIGO clinical prac-

tice guideline for acute kidney injury. Kidney Int Suppl.

2012;2:1-138. https://doi.org/10.1038/kisup.2012.1v

McCullough PA, Bouchard J, Waikar SS, et al.

Implementation of novel biomarkers in the diagnosis,

prognosis, and management of acute kidney injury:

executive summary from the tenth consensus confer-

ence of the Acute Dialysis Quality Initiative (ADQI).

Contrib

Nephrol.

2013;182:5-12.

https://doi.

org/10.1159/000349962

Mehta RL, Awdishu L, Davenport A, et al. Phenotype

standardization for drug-induced kidney disease.

Kidney Int. 2015;88(2):226-234. https://doi.org/10.1038/

ki.2015.115

Miano TA, Hennessy S, Yang W, et al. Association of

vancomycin plus piperacillin-tazobactam with early

changes in creatinine versus cystatin C in critically

Med.

2022;48(9):1144-1155.

https://doi.org/10.1007/

s00134-022-06811-0

Ostermann M, Bellomo R, Burdmann EA, et al.

Controversies in acute kidney injury: conclusions from a

Kidney Disease: Improving Global Outcomes (KDIGO)

conference. Kidney Int. 2020;98(2):294-309. https://doi.

org/10.1016/j.kint.2020.04.020

O’Sullivan ED, Doyle A. The clinical utility of kinetic

glomerular filtration rate. Clin Kidney J. 2017;10(2):202-

208. https://doi.org/10.1093/ckj/sfw108

Pais GM, Liu J, Avedissian SN, et al. Lack of synergis-

tic nephrotoxicity between vancomycin and piperacillin/

tazobactam in a rat model and a confirmatory cellular

model. J Antimicrob Chemother. 2020;75(5):1228-1236.

https://doi.org/10.1093/jac/dkz563

Schreier DJ, Kashani KB, Sakhuja A, et al. Incidence

of acute kidney injury among critically ill patients with

brief empiric use of antipseudomonal β-lactams with

vancomycin. Clin Infect Dis. 2019;68(9):1456-1462.

https://doi.org/10.1093/cid/ciy724